vs

Side-by-side financial comparison of La Rosa Holdings Corp. (LRHC) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.

Pulmonx Corp is the larger business by last-quarter revenue ($20.6M vs $20.2M, roughly 1.0× La Rosa Holdings Corp.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -66.3%, a 39.0% gap on every dollar of revenue. On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -8.7%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs -0.5%).

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

LRHC vs LUNG — Head-to-Head

Bigger by revenue
LUNG
LUNG
1.0× larger
LUNG
$20.6M
$20.2M
LRHC
Growing faster (revenue YoY)
LRHC
LRHC
+11.8% gap
LRHC
3.2%
-8.7%
LUNG
Higher net margin
LRHC
LRHC
39.0% more per $
LRHC
-27.4%
-66.3%
LUNG
Faster 2-yr revenue CAGR
LRHC
LRHC
Annualised
LRHC
72.5%
-0.5%
LUNG

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
LRHC
LRHC
LUNG
LUNG
Revenue
$20.2M
$20.6M
Net Profit
$-5.5M
$-13.7M
Gross Margin
8.4%
77.9%
Operating Margin
-24.7%
-40.9%
Net Margin
-27.4%
-66.3%
Revenue YoY
3.2%
-8.7%
Net Profit YoY
-125.7%
5.5%
EPS (diluted)
$-5.44
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LRHC
LRHC
LUNG
LUNG
Q1 26
$20.6M
Q4 25
$22.6M
Q3 25
$20.2M
$21.5M
Q2 25
$23.2M
$23.9M
Q1 25
$17.5M
$22.5M
Q4 24
$17.7M
$23.8M
Q3 24
$19.6M
$20.4M
Q2 24
$19.1M
$20.8M
Net Profit
LRHC
LRHC
LUNG
LUNG
Q1 26
$-13.7M
Q4 25
$-10.4M
Q3 25
$-5.5M
$-14.0M
Q2 25
$78.4M
$-15.2M
Q1 25
$-95.7M
$-14.4M
Q4 24
$-5.1M
$-13.2M
Q3 24
$-2.5M
$-14.1M
Q2 24
$-2.3M
$-15.3M
Gross Margin
LRHC
LRHC
LUNG
LUNG
Q1 26
77.9%
Q4 25
77.6%
Q3 25
8.4%
74.7%
Q2 25
8.0%
72.1%
Q1 25
8.8%
72.5%
Q4 24
8.9%
74.0%
Q3 24
8.3%
73.7%
Q2 24
8.3%
73.7%
Operating Margin
LRHC
LRHC
LUNG
LUNG
Q1 26
-40.9%
Q4 25
-43.8%
Q3 25
-24.7%
-66.9%
Q2 25
-10.6%
-62.0%
Q1 25
-26.7%
-64.6%
Q4 24
-17.1%
-56.5%
Q3 24
-8.9%
-69.3%
Q2 24
-9.7%
-75.2%
Net Margin
LRHC
LRHC
LUNG
LUNG
Q1 26
-66.3%
Q4 25
-46.1%
Q3 25
-27.4%
-64.9%
Q2 25
337.8%
-63.6%
Q1 25
-546.5%
-64.1%
Q4 24
-28.7%
-55.4%
Q3 24
-12.5%
-69.4%
Q2 24
-12.2%
-73.7%
EPS (diluted)
LRHC
LRHC
LUNG
LUNG
Q1 26
$-0.33
Q4 25
$-0.25
Q3 25
$-5.44
$-0.34
Q2 25
$15.25
$-0.38
Q1 25
$-5.86
$-0.36
Q4 24
$28.54
$-0.33
Q3 24
$-16.49
$-0.36
Q2 24
$-12.49
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LRHC
LRHC
LUNG
LUNG
Cash + ST InvestmentsLiquidity on hand
$4.0M
$61.6M
Total DebtLower is stronger
$642.8K
$37.3M
Stockholders' EquityBook value
$1.6M
$45.8M
Total Assets
$21.7M
$120.0M
Debt / EquityLower = less leverage
0.41×
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LRHC
LRHC
LUNG
LUNG
Q1 26
$61.6M
Q4 25
$69.8M
Q3 25
$4.0M
$76.5M
Q2 25
$5.1M
$75.5M
Q1 25
$2.9M
$74.6M
Q4 24
$1.4M
$70.9M
Q3 24
$1.8M
$63.3M
Q2 24
$1.6M
$63.5M
Total Debt
LRHC
LRHC
LUNG
LUNG
Q1 26
$37.3M
Q4 25
$37.1M
Q3 25
$642.8K
$37.1M
Q2 25
$644.3K
$37.1M
Q1 25
$645.9K
$37.2M
Q4 24
$647.6K
$37.2M
Q3 24
$649.2K
$37.2M
Q2 24
$650.8K
$37.2M
Stockholders' Equity
LRHC
LRHC
LUNG
LUNG
Q1 26
$45.8M
Q4 25
$54.1M
Q3 25
$1.6M
$60.0M
Q2 25
$3.4M
$69.1M
Q1 25
$-87.5M
$77.7M
Q4 24
$2.6M
$85.8M
Q3 24
$5.0M
$93.9M
Q2 24
$4.7M
$101.2M
Total Assets
LRHC
LRHC
LUNG
LUNG
Q1 26
$120.0M
Q4 25
$129.3M
Q3 25
$21.7M
$138.3M
Q2 25
$22.9M
$147.2M
Q1 25
$21.0M
$150.7M
Q4 24
$19.4M
$162.8M
Q3 24
$19.7M
$167.4M
Q2 24
$18.7M
$172.6M
Debt / Equity
LRHC
LRHC
LUNG
LUNG
Q1 26
0.82×
Q4 25
0.69×
Q3 25
0.41×
0.62×
Q2 25
0.19×
0.54×
Q1 25
0.48×
Q4 24
0.25×
0.43×
Q3 24
0.13×
0.40×
Q2 24
0.14×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LRHC
LRHC
LUNG
LUNG
Operating Cash FlowLast quarter
$-1.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LRHC
LRHC
LUNG
LUNG
Q1 26
Q4 25
$-7.1M
Q3 25
$-1.3M
$-8.2M
Q2 25
$-1.4M
$-3.9M
Q1 25
$-3.5M
$-13.2M
Q4 24
$-1.1M
$-6.7M
Q3 24
$-591.6K
$-7.2M
Q2 24
$-803.1K
$-5.8M
Free Cash Flow
LRHC
LRHC
LUNG
LUNG
Q1 26
Q4 25
$-7.1M
Q3 25
$-8.3M
Q2 25
$-4.0M
Q1 25
$-13.5M
Q4 24
$-6.8M
Q3 24
$-7.7M
Q2 24
$-6.2M
FCF Margin
LRHC
LRHC
LUNG
LUNG
Q1 26
Q4 25
-31.4%
Q3 25
-38.4%
Q2 25
-16.6%
Q1 25
-60.0%
Q4 24
-28.8%
Q3 24
-37.6%
Q2 24
-30.0%
Capex Intensity
LRHC
LRHC
LUNG
LUNG
Q1 26
Q4 25
0.1%
Q3 25
0.4%
Q2 25
0.2%
Q1 25
1.3%
Q4 24
0.5%
Q3 24
2.0%
Q2 24
2.3%
Cash Conversion
LRHC
LRHC
LUNG
LUNG
Q1 26
Q4 25
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

LUNG
LUNG

Segment breakdown not available.

Related Comparisons